Stereotactic Body Radiation Therapy for Prostate Cancer: What is the Appropriate Patient-Reported Outcome for Clinical Trial Design?

Purpose: Stereotactic body radiation therapy (SBRT) is increasingly utilized as primary treatment for clinically localized prostate cancer. Consensus regarding the appropriate patient-reported outcome (PRO) endpoints for clinical trials evaluating radiation modalities for early stage prostate cancer...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Oncol
Autores principales: Woo, Jennifer Ai-Lian, Chen, Leonard N., Wang, Hongkun, Cyr, Robyn A., Bhattasali, Onita, Kim, Joy S., Moures, Rudy, Yung, Thomas M., Lei, Siyuan, Collins, Brian Timothy, Suy, Simeng, Dritschilo, Anatoly, Lynch, John H., Collins, Sean P.
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2015
Materias:
Oncology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4379875/
https://ncbi.nlm.nih.gov/pubmed/25874188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2015.00077
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares